Overview

Bivalirudin vs Heparin in ECMO Patients

Status:
Withdrawn

Trial end date:
2021-06-01

Target enrollment:

Participant gender:

Summary

This is an open label, randomized study comparing the clinical outcomes of unfractionated Heparin and Bivalirudin for anticoagulation in adult subjects requiring ECMO support.

Phase:

Phase 1

Details

Lead Sponsor:

Johns Hopkins University

Treatments:

Bivalirudin
Calcium heparin
Heparin
Hirudins